Local control and outcome in children with localized vaginal rhabdomyosarcoma: A report from the Soft Tissue Sarcoma committee of the Children's Oncology Group

The local control approach for girls with non‐resected vaginal rhabdomyosarcoma (RMS) enrolled onto Intergroup RMS Study Group (IRSG)/Children's Oncology Group (COG) studies has differed from that used at other primary sites by delaying or eliminating radiotherapy (RT) based on response achieved with chemotherapy and delayed primary resection.

[1]  James R. Anderson,et al.  Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  C. Haie-meder,et al.  Vulval and vaginal rhabdomyosarcoma in children: update and reappraisal of Institut Gustave Roussy brachytherapy experience. , 2008, International journal of radiation oncology, biology, physics.

[3]  M. Hudson,et al.  Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  H. B. Marsden,et al.  Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  James R. Anderson,et al.  Rhabdomyosarcoma: many similarities, a few philosophical differences. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  R. D. de Haan,et al.  Quality of life, self‐esteem and worries in young adult survivors of childhood cancer , 2004, Psycho-oncology.

[7]  James R. Anderson,et al.  Age is a risk factor for chemotherapy-induced hepatopathy with vincristine, dactinomycin, and cyclophosphamide. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  M. Grootenhuis,et al.  Quality of life in young adult survivors of childhood cancer , 2002, Supportive Care in Cancer.

[9]  I. Leuschner,et al.  Rhabdomyosarcoma of the Urinary Bladder and Vagina: A Clinicopathologic Study With Emphasis on Recurrent Disease: A Report From the Kiel Pediatric Tumor Registry and the German CWS Study , 2001, The American journal of surgical pathology.

[10]  James R. Anderson,et al.  Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  James R. Anderson,et al.  What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? , 2001, Cancer.

[12]  L. Diller,et al.  High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood , 2001, Cancer.

[13]  C. Haie-meder,et al.  Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: A report from the Study Committee of the International Society of Pediatric Oncology. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  S. Qualman,et al.  Progress in the surgical management of vaginal rhabdomyosarcoma: a 25-year review from the Intergroup Rhabdomyosarcoma Study Group. , 1999, Journal of pediatric surgery.

[15]  Timothy J. Triche,et al.  Intergroup Rhabdomyosarcoma Study: Update for Pathologists , 1998, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[16]  E. Gehan,et al.  The Third Intergroup Rhabdomyosarcoma Study. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Nihoul-Fékété,et al.  Long-term sequelae of conservative treatment by surgery, brachytherapy, and chemotherapy for vulval and vaginal rhabdomyosarcoma in children. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[19]  S. Donaldson,et al.  Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report. , 1994, Medical and pediatric oncology.

[20]  R. Wittes,et al.  Methodologic guidelines for reports of clinical trials. , 1985, Cancer treatment reports.